INTRODUCTION
The Fanconi anemia (FA) pathway ( Figure 1A ) plays a key role in interstrand crosslink (ICL) metabolism in higher eukaryotes by coordinating S phase arrest and DNA repair (Moldovan and D'Andrea, 2009; Thompson and Hinz, 2009) . Replication fork blockage activates the ataxia telangiectasia and RAD3-related (ATR) kinase (Pichierri and Rosselli, 2004) , which phosphorylates members of the FA core complex (Meetei et al., 2003) composed of FANCA, B, C, E, F, G, L, and FAAP100. The activated complex then associates with FANCM-FAAP24, a DNA translocase (Gari et al., 2008) , which activates the E3 ligase FANCL that subsequently ubiquitylates FANCD2-FANCI (Thompson and Hinz, 2009 ). The latter posttranslational modifications license the processing of the blocked replication fork ( Figure 1A ), which involves pausing of the fork, incision, lesion unhooking, translesion DNA synthesis (TLS), and homologous recombination (HR) (Moldovan and D'Andrea, 2009 ). FANCJ, a 5 0 /3 0 DNA helicase, appears to be involved in the late stages of ICL repair (Bridge et al., 2005) . Its action would give rise to 3 0 flaps, preferred substrates of both endonucleases implicated in ICL processing to date, MUS81/EME1 and XPF/ERCC1.
Recently, several laboratories found interaction between FA proteins and polypeptides involved in mismatch repair (Peng et al., 2007; Zhang et al., 2002) . Our analysis of the MLH1 interactome (Cannavo et al., 2007) identified FANCJ among the strongest interactors. Another strong MLH1 interactor was KIAA1018, a hypothetical protein predicted (Kinch et al., 2005; Kosinski et al., 2005) to contain a RAD18-like ubiquitin-binding zinc finger near its N terminus and a C-terminal endonuclease domain. Given the importance of ubiquitylation in the FA pathway (Moldovan and D'Andrea, 2009) , and the fact that the putative endonuclease domain of KIAA1018 belongs to the same enzyme superfamily as those present in MUS81 and XPF, we asked whether KIAA1018 is related to FA and how mismatch repair (MMR) might be linked to this branch of DNA repair. Hence, we decided to characterize KIAA1018 and to study its role in DNA metabolism. We now show that KIAA1018 is a nuclease involved in the processing of mitomycin C (MMC)-and cisplatin-induced DNA damage, to which it is recruited by ubiquitylated FANCD2.
RESULTS

KIAA1018 Contains Evolutionarily Conserved Zinc Finger and Endonuclease Domains
Analysis of MLH1 and PMS2 interactomes (Cannavo et al., 2007) identified several peptides originating from the human KIAA1018 open reading frame (ORF), which encodes a polypeptide of 1017 amino acids (aa) . Its N-terminal region was predicted to contain a RAD18-like CCHC zinc finger, a so-called UBZ domain, present in proteins that bind ubiquitylated polypeptides (Hofmann, 2009 ). The C-terminal portion of KIAA1018 was suggested to contain an endonuclease domain of the PD-D/E(X)K type (Kinch et al., 2005; Kosinski et al., 2005) (Figure 1B) .
Alignment of the aa sequences of human, murine, avian, and C. elegans KIAA1018 revealed a high degree of evolutionary conservation, particularly in the UBZ region ( Figure 1C ) and in the putative endonuclease PD-D/E(X)K motif ( Figure 1D ), which is found in other DNA repair proteins, such as the bacterial MMR protein MutH, certain restriction enzymes, and, most notably, the eukaryotic MUS81 and XPF/RAD1 endonucleases ( Figure 1E ).
Depletion of KIAA1018 Sensitizes Human Cells to Interstrand Crosslinking Agents
We asked whether KIAA1018 deficiency sensitizes cells to a particular type of DNA damage. To this end, we knocked down KIAA1018 mRNA in HEK293 cells by siRNA targeting exon 3 ( Figure 2A ) and subjected these cells to treatment with several DNA-damaging agents. Compared to wild-type (WT) controls, the KIAA1018 knockdown cells were not significantly sensitized to X-rays ( Figure 2B ), UV irradiation ( Figure 2C ), or camptothecin ( Figure 2D ). In contrast, KIAA1018-deficient cells were hypersensitive to the ICL-inducing agents MMC ( Figure 2E ) and cisplatin ( Figure 2F ), similarly to cells deficient in FANCJ (Figures 2A, 2E, and 2F) . siRNA targeting exon 5 yielded similar results (data not shown); the above phenotype was thus not caused by an off-site effect of the siRNA.
KIAA1018 Requires Its Putative Nuclease Domain for Activity
We generated HEK293 cell lines stably expressing KIAA1018 N-terminally fused to the green fluorescent protein (GFP). The GFP-KIAA1018 fusion cDNAs encoded either the WT enzyme or a variant carrying a D960A (DA) mutation in its predicted nuclease active site. The cDNAs also contained silent mutations in the KIAA1018 ORF, which made the respective mRNAs resistant to knockdown by exon 3 siRNA. As shown in Figure S1A (available online), the selected clones expressed similar levels of the GFP-WT and GFP-DA variants. Treatment of these cells with Luc siRNA did not affect their sensitivity to MMC. When KIAA1018 siRNA was used, the sensitivity of the GFP-WT clone was also unaffected, whereas the GFP-DA clones were sensitized to MMC treatment ( Figure 2G ). This result confirms that the phenotype induced by the KIAA1018 siRNA was not due to an off-target effect, demonstrates that the GFP-WT fusion
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Ub P I Ub P (Moldovan and D'Andrea, 2009; Wang, 2007) . Upon stalling of the replication fork, the FA core complex is phosphorylated on several subunits by ATR and recruited to the lesion by FANCM/FAAP24. This interaction activates the E3 ligase activity of FANCL (a), which monoubiquitylates the FANCD2/FANCI heterodimer (b). The fork is then cleaved by MUS81 on one side and unhooked by XPF/ ERCC1 on the other (c and d). Translesion polymerases then fill the gap opposite the unhooked oligonucleotide (e), which is released by excision repair (f). The collapsed replication fork is then rescued by the HR machinery, including FANCD1 (BRCA2), FANCN (PALB2), and likely also FANCJ (f and g).
(B) KIAA1018 is a polypeptide of 1017 aa, containing a predicted N-terminal RAD18-like CCHC zinc finger and a C-terminal endonuclease domain. Alignments of the zinc finger (C) and endonuclease (D) domains of KIAA1018 from man, mouse, chicken, and worm are shown. (E) Alignment of the endonuclease domain of human KIAA1018 with those of human MUS81 and XPF and their yeast orthologs Mus81 and Rad1, respectively. Identical residues are shown in bold. The key residues of the zinc finger and endonuclease motifs are boxed. The numbers indicate aa residues flanking these motifs in the respective KIAA1018 open reading frames. Asterisks mark aa mutated to alanine (see Results).
protein is functional, and, most importantly, shows that the nuclease domain is indispensable for KIAA1018 function.
Disruption of the KIAA1018 Ortholog C01G5.8 in C. elegans Leads to Cisplatin-Induced Embryonic Lethality KIAA1018 is highly conserved in evolution ( Figures 1C and 1D) . In order to ascertain that the above-described sensitivity to ICL-inducing agents was not limited to KIAA1018-depleted human cells, we examined the phenotype of C. elegans disrupted in the KIAA1018 ortholog C01G5.8 ( Figure S1B ). The C01G5.8(tm423) mutant developed similarly to WT (data not shown), which showed that C01G5.8 is not required for normal growth. Cisplatin treatment caused a dramatic increase in embryonic lethality in the C01G5.8(tm423) mutants, whereas the viability of WT worms was only slightly impaired ( Figure 2H ).
We next generated the transgenic C. elegans line opIs406 (P C01G5.8 ::C01G5.8::gfp) ( Figure S1C ). Like the human ortholog, the nematode GFP fusion protein overexpressed in this line was functional, as it rescued the cisplatin-sensitive phenotype of the C01G5.8(tm423) mutants ( Figure 2I ). Because treatment with ultraviolet (UV) ( Figure 2J ) or ionizing radiation (IR) ( Figure 2K ) had a similar effect on both WT and mutant animals, we conclude that C01G5.8 functions in the repair of cisplatininduced damage during embryonic development. The sensitization to cisplatin of both human cells and C. elegans lacking KIAA1018 or its ortholog C01G5.8 suggests that the function of this protein family in the processing of DNA damage is evolutionarily conserved.
KIAA1018/C01G5.8 Localization to Subnuclear Foci Is Enhanced by DNA Damage As the GFP fusion proteins were functional, we decided to study their localization. In actively proliferating cells, namely embryos ( Figures 3A and 3B ) and germ cells of the mitotic region ( Figures  3C and 3D) , we observed both an evenly distributed as well as Figures 3H-3J ). Aggregation in subnuclear foci is a hallmark of proteins participating in DNA-damage response. As C01G5.8::gfp formed foci in cisplatin-treated cells, we wanted to know whether human KIAA1018 acted similarly. Untreated cells contained a small number of foci of GFP-KIAA1018, FANCD2, and Replication Protein A (RPA, marker of long stretches of single-stranded DNA). Upon cisplatin (data not shown) and MMC treatment, the number of foci rose dramatically, and GFP-KIAA1018 colocalized in them with both FANCD2 ( Figure 3K ) and RPA ( Figure 3L ).
FANC Complex Signaling Is Unaffected in KIAA1018-Depleted Cells
Given that sensitivity to ICL-inducing agents is a hallmark of FA cells, and that KIAA1018 colocalizes to DNA-damage foci with FANCD2, we suspected that KIAA1018 might be linked to the FA pathway. We therefore asked whether KIAA1018 deficiency affects activation of the FA complex, which can be detected as monoubiquitylation of FANCD2 and FANCI (Garcia-Higuera As shown in Figure 4A , treatment of HEK293 cells with MMC or hydroxyurea (HU) resulted in substantial FANCD2 ubiquitylation, but this process was unaffected by KIAA1018 knockdown. A similar phenomenon was observed in cells lacking FANCJ (Bridge et al., 2005) . Thus, if KIAA1018 were linked to the FA pathway, it would-like FANCJ-act downstream of the FA complex.
Human Cells Lacking FANCD2, KIAA1018, or Both Proteins Display Similar Sensitivities to MMC Given that GFP-KIAA1018 and FANCD2 colocalize to DNA-damage-induced foci, we asked whether KIAA1018 and FANCD2 were epistatic. We therefore knocked down KIAA1018 and FANCD2, either singly or together, in HEK293 cells ( Figure 4B ). As shown in Figure 4C , cells lacking both proteins were not appreciably more sensitive to MMC than cells lacking only one of these polypeptides. This suggests that KIAA1018 might be epistatic with the FA proteins, although a stable system is necessary to exclude the possibility of an incomplete knockdown in cells treated with both siRNAs.
The Zinc Finger of KIAA1018 Is Necessary and Sufficient for Targeting the Protein to Sites of DNA Damage KIAA1018 possesses a UBZ motif close to its N terminus (Figures 1B and 1C) . In other polypeptides, this motif has been shown to interact with ubiquitylated polypeptides (Hofmann, 2009) . In order to characterize the function of the UBZ of KIAA1018, we expressed in E. coli glutathione S-transferase (GST) fused to KIAA1018 aa 1-124 containing either the WT UBZ or a variant in which the UBZ was disrupted by mutating cysteines 44 and 47 to alanines ( Figure 1C ). As zinc finger domains are also known to bind DNA, we tested these peptides in a mobility shift assay, using a homoduplex 38-mer oligonucleotide. We found no evidence of the GST-fusions interacting with DNA in this assay, even though the mismatch binding factor MutSa bound to the homoduplex (a poor substrate for this protein) under identical conditions ( Figure S2A ).
We then studied the MMC response of the GFP-KIAA1018 WT and CACA variants stably expressed in U2OS cells. We generated two additional cell lines expressing solely the N-terminal 124 aa residues encoding either the WT or the mutant UBZ. Expression of these variants in U2OS cells, followed by treatment with MMC, resulted in the formation of foci in cells expressing WT GFP-KIAA1018 and the 124 aa UBZ only. These foci colocalized with those formed by FANCD2. In contrast, both KIAA1018-CACA variants diffused throughout the nucleus and failed to form foci upon MMC treatment, even though FANCD2 foci formed normally ( Figure 4D and Figure S2B ). siRNA-mediated knockdown of endogenous KIAA1018 in cells expressing the KIAA1018 GFP-UBZ fragment did not alter the targeting to the MMC-induced foci, thus excluding the possibility that GFP-UBZ localizes to the damage sites via association with the endogenous protein (data not shown). This Where indicated, cells were incubated with 20 mM MG132 for 120 min before irradiation. GFP-KIAA1018 fails to be recruited to damage stripes in the absence of ubiquitylation. (F) U2OS cells stably expressing GFP-KIAA1018-WT were treated with luciferase or FANCD2 siRNAs for 48 hr. Treatment with 120 ng/ml MMC for 16 hr was followed by immunostaining with anti-FANCD2 antibody. GFP-KIAA1018 is not recruited to damage foci in the absence of FANCD2. (G) PD20 (FA-D2) fibroblasts (top row), PD20 fibroblasts stably expressing FANCD2-WT (middle row), or FANCD2-K561R mutant (bottom row) were transiently transfected with GFP-KIAA1018-WT, treated with 120 ng/ml MMC for 16 hr, and immunostained with anti-FANCD2 antibody. GFP-KIAA1018 only localizes to damage foci in cells expressing the WT FANCD2 protein.
(H) Extracts of HEK293 cells stably expressing GFP-KIAA1018-WT or GFP-KIAA1018-CACA and treated with 120 ng/ml MMC were incubated with anti-GFP antibody and the immunoprecipitate was analyzed with antibodies against GFP or FANCD2. GFP-KIAA1018 interacts preferentially with the monoubiqyitylated form of FANCD2. See Figure S2 for quantifications.
suggested that the UBZ is necessary and sufficient to target GFP-KIAA1018 to DNA-damage foci generated by MMC treatment.
Recruitment of KIAA1018 to DNA-Damage Foci Is Dependent on FANCD2 Ubiquitylation We wanted to know whether KIAA1018 targeting to MMCinduced foci was dependent on ubiquitylation, similarly to that described for FANCD2 (Garcia-Higuera et al., 2001) . To this end, we pretreated the U2OS cells stably expressing GFP-KIAA1018 with MG132, an inhibitor of the 26S proteasome, which also causes sequestration of ubiquitin in the cytoplasm (Dantuma et al., 2006) . We then generated DNA damage by a UV microlaser, which induces a variety of DNA lesions concentrated in micron-thin stripes and causes a substantial perturbation of chromatin structure, which brings about rapid recruitment of the phosphorylated form of the histone variant g-H2AX.
As shown in Figure 4E and Figure S2C , GFP-KIAA1018 and g-H2AX colocalized in the laser stripes, but the KIAA1018 signal remained diffuse in MG132 pretreated cells. This indicated that KIAA1018 recruitment to DNA damage in chromatin required nuclear ubiquitin.
In the above experiments, we showed that MMC treatment of U2OS cells stably expressing GFP-KIAA1018 induced the formation of KIAA1018 foci ( Figures 3K and 3L) , that FANCD2 colocalized with GFP-KIAA1018 to these foci ( Figure 3K ), and that KIAA1018 was recruited to laser-induced stripes in a ubiquitin-dependent manner ( Figure 4E ). As no KIAA1018 foci were formed in cells in which FANCD2 mRNA was knocked down with either one of two different siRNAs (Figures 4B and 4F, Figure S2D , and data not shown), we concluded that KIAA1018 recruitment to DNA-damage foci required ubiquitin and FANCD2.
This hypothesis could be further substantiated in the FANCD2-mutated cell line PD20, which displayed no MMCinduced foci of GFP-KIAA1018 ( Figure 4G , top row; see also Figure S2E ). The phenotype of this cell line could be rescued by expression of FANCD2 cDNA; in the latter cell line, FANCD2 and GFP-KIAA1018 colocalized to MMC-induced foci ( Figure 4G , middle row; Figure S2E ). In contrast, when the cells were stably transfected with a FANCD2 K561R variant that cannot be ubiquitylated (Garcia-Higuera et al., 2001) , both proteins failed to form foci upon MMC treatment ( Figure 4G , bottom row; Figure S2E ).
The above evidence strongly suggested that KIAA1018 is recruited to MMC-induced foci by monoubiquitylated FANCD2, likely in complex with FANCI. We therefore asked whether KIAA1018 and FANCD2 interact directly. Using anti-GFP antibodies, we immunoprecipitated the GFP-KIAA1018 fusion protein, or its CACA UBZ variant, from extracts of stably transfected, MMC-treated HEK293 cells, and probed the immunoprecipitates for the presence of FANCD2. As shown in Figure 4H , the GFP antibodies pulled down WT GFP-KIAA1018 and both the unmodified and the monoubiquitylated forms of FANCD2. Notably, only the unmodified form was present in the GFP-KIAA1018-CACA pull-down, which shows that KIAA1018 interacts specifically with the monoubiquitylated form of FANCD2 via its UBZ domain.
KIAA1018 Is a Nuclease
As bioinformatic analysis of the KIAA1018 ORF predicted the protein to be an endonuclease (Kinch et al., 2005; Kosinski et al., 2005) , and given that the protein appears to protect cells against ICL-generating substances, we asked whether the protein is indeed a nuclease.
We expressed full-length KIAA1018 in E. coli fused to an N-terminal Nus-His-tag (Ermolova et al., 2003) to aid solubility and purified the fusion protein to apparent homogeneity ( Figures  S3A and S3B) . To test for nucleolytic activity, we deployed a nonspecific endonuclease assay (Kadyrov et al., 2007) . Incubation of supercoiled plasmid DNA with increasing amounts of the Nus-His-KIAA1018 fusion protein in the presence of manganese and 100 mM KCl gave rise first to open circular, then linear forms ( Figure 5A , Figure S3C) , showing that KIAA1018 cleaved the substrate endonucleolytically. At the highest concentrations, the linearized DNA was degraded, which suggested that the enzyme is also an exonuclease. The UBZ-CACA variant was similarly active as the WT enzyme, but the two variants carrying mutations in the putative nuclease active site, D960A (DA) and K977A (KA), were severely impaired at equal protein concentrations ( Figure 5A and Figures S3A-S3C ). The loss of nuclease activity of the latter two variants was apparently not linked to incorrect folding or other structural perturbation, as the proteins were still able to bind DNA in a gel shift assay ( Figure S3D ).
Most metal-dependent nucleases can be inhibited either by chelating agents or by zinc or calcium. This is also true for KIAA1018, which could be effectively inhibited by EDTA or by zinc chloride ( Figure 5B ). The enzyme displayed optimal activity at pH 7.2-7.4 and 25 mM KCl in the presence of manganese. When magnesium was used, the endonucleolytic activity was somewhat reduced, but the degradation of DNA was restricted ( Figure S3E ). Under optimized conditions and when used in large excess, the KA variant possessed residual nuclease activity in the plasmid relaxation assay ( Figure S3F ). For this reason, we decided to use the WT and the DA variant in the search for specific substrates of KIAA1018.
KIAA1018 Preferentially Cleaves 5
0 Flaps and Has Both Exo-and Endonuclease Activities In the above experiments, to aid solubility we used bacterially expressed KIAA1018 carrying a 55 kDa Nus-His tag. In order to ensure that its activity was unaffected by the tag or by the lack of posttranslational modifications, we expressed KIAA1018 and its DA variant in the baculovirus system. An N-terminal maltose-binding protein (MBP) tag was used to express the protein, but this was removed during purification ( Figures S4A and S4B) . We tested the untagged enzyme on different oligonucleotide structures resembling intermediates of replication and recombination ( Figure S4C ). We used magnesium as the divalent ion because proteins of the PD-(D/E)XK nuclease superfamily are all magnesium dependent.
We first used substrates labeled at the 5 0 end of the top strand ( Figure S4C , f9) and could show that KIAA1018 cleaved them in the following order of preference: 5 0 flap > > > splayed arm z3-way junction (3-WJ) > 3 0 flap. The principal products were fragments between 31 and 35 nucleotides in length. As the flap was 30 nucleotides long, this indicated that the enzyme cleaved the substrates in double-stranded (ds) DNA, 1-5 nucleotides downstream from the junction ( Figure 6A and Figure S4C , large arrow). In the reactions containing the 3-WJ, 3 0 flap, and, to a small extent, also the splayed arm substrate, we also detected very fast-migrating species, which corresponded in length to 2-4 nucleotides. This suggested that KIAA1018 is also a 5 0 /3 0 exonuclease, as already anticipated from the preliminary assays ( Figure 5A ). We could confirm this by labeling the same substrates at the 5 0 end of the bottom strand ( Figure 6A ). In these assays, all substrates gave rise to a pentamer fragment. (The exonucleolytic cleavage products differed in length between the substrates labeled in the top or the bottom strands because the latter was one nucleotide longer. See Figure S4C .) This shows that KIAA1018 can generate 5 0 -recessed ends from blunt-ended substrates and that the enzyme makes the first incision 4 nucleotides into the ds region on these substrates ( Figure S4C , small arrows). Interestingly, although the exonuclease activity of KIAA1018 on ds termini was robust, the 5 0 flap substrate was processed to yield predominantly the single-stranded (ss) 31-to 35-mer flap and only small amounts of the rapidly migrating species. This suggested that the enzyme did not degrade the cleaved-off ss flap with appreciable efficiency. We could confirm this by incubating the 5 0 flap substrate with increasing amounts of enzyme. As shown in Figure 6B , the amount of free ss flap fragments increased with enzyme concentration, but only a minor increase in the high-mobility species was observed.
Next we labeled the substrates at the 3 0 end. As shown in Figure 6C , the 5 0 flap substrate gave rise to a series of bands ranging in length from approximately 10-29 nucleotides, which represent products of 5 0 /3 0 exonucleolytic degradation of the labeled strand after the flap was cleaved off ( Figure 6F ). Interestingly, while the 5 0 -labeled 3-WJ (f9 strand) was cleaved with very low efficiency (Figure 6A ), the same substrate labeled at the 3 0 end of the same (f9) strand appeared to be endonucleolytically cleaved and then exonucleolytically degraded with efficiency similar to the 5 0 flap. By 3 0 -labeling the 30-mer (f7) of the 3-WJ, we could show that this oligomer was rapidly degraded, creating thus a 5 0 flap substrate that was then efficiently processed by KIAA1018 ( Figure 6D ).
The bacterially expressed KIAA1018 used in comparable amounts ( Figure S4B ) behaved in these assays similarly in magnesium (data not shown) and in manganese ( Figures S4D  and S4E ). However, although manganese increased KIAA1018 0 s enzymatic activity, it decreased its specificity.
That the cleaved-off 5 0 flap ( Figures 6A and 6B ) was not further processed by the enzyme is supported by the fact that ssDNA was not appreciably bound by the enzyme in a gel shift assay, whereas linear dsDNA, 5 0 flap and 3 0 flap substrates were bound with similar efficiencies ( Figure S4F) .
In an attempt to study the substrate preference of KIAA1018 exonuclease, we incubated the enzyme with several different substrates. As shown in Figure 6E and Figure S4G , KIAA1018 exonuclease activity displayed a clear preference for dsDNA substrates containing a recessed 5 0 end, a nick, or a gap. Blunt-ended DNA was processed less efficiently and the worst substrates were ssDNA and ss 5 0 overhangs, as anticipated from the stability of the cleaved-off 5 0 flap ( Figure 6B ). To test whether the substrate specificity of KIAA1018 might be altered by an as-yet-unidentified interacting partner, we immunoprecipitated the enzyme from HEK293 cells stably expressing either FLAG-tagged KIAA1018 WT or the DA variant. The immunoprecipitate of the WT enzyme displayed the same substrate preference as the bacterially expressed and the Sf9-expressed proteins ( Figures 6A and 6H, Figure S4D ). However, it appeared to be more specific, giving rise to a single product upon incubation with the 5 0 flap substrate (cf. product in Figure 6A ). This change was not due to MLH1, as coexpression of KIAA1018 with MLH1 did not affect the outcome of the nuclease assays (data not shown). We are currently analyzing the interactome of KIAA1018 in search for possible partners of this nuclease. The substrate spectrum of KIAA1018 resembles that of FEN1, which displays preference for 5 0 flaps (Harrington and Lieber, 1994) . However, unlike KIAA1018, FEN1 made only a single cut, at the end of the ss flap ( Figure 6G ). In contrast, MUS81/ EME1 failed to cleave the 5 0 flap substrate but showed a clear preference for 3 0 flaps, as reported (Kaliraman et al., 2001) . We also included two D loop structures and a bubble in these experiments, as intermediates of recombination, but also as structures that arise transiently during DNA replication and transcription, processes blocked by cisplatin and MMC. Interestingly, the 5 0 flaps of the D loop proved to be processed by the KIAA1018 endonuclease activity with similar efficiency to the 5 0 flap, whereas only the exonuclease acted on the bubble and the 3 0 flap substrates ( Figure 6G, right panel) .
The DA variant was used in parallel with the WT enzyme in the above assays. As processing of the tested substrates was almost undetectable (Figure 6, Figure S4 ), we conclude that (H) FLAG-KIAA1018 immunoprecipitated from stably transfected HEK293 cells showed the same specificity as the bacterially and Sf9-expressed recombinant KIAA1018 protein but made a more defined cut at the DNA junction. All assays shown in this figure were carried out in magnesium. Samples were separated on denaturing 20% polyacrylamide gels for 1 hr at 40V/cm. The radioactive species were visualized by PhosphoImager (Typhoon 9400). M, oligonucleotide markers; WT, KIAA1018-WT; DA, KIAA1018 variant D960A. 3-WJ, 3-way junction. See Figure S4 for supplemental information.
both the exo-and the endonuclease activities are inherent to the same active site of KIAA1018, rather than to a contaminant in the purified fractions.
KIAA1018 Is Involved in the Repair of MMC-Induced Double-Strand Breaks
As shown in Figure 1A , processing of ICLs was suggested to involve endonucleolytic cleavage of the blocked replication forks by MUS81/EME1 and/or XPF/ERCC1. These one-ended doublestrand breaks (DSBs) can be visualized directly by pulse-field gel electrophoresis (De Silva et al., 2000; Hanada et al., 2006) , or indirectly as subnuclear foci of phosphorylated histone H2AX (g-H2AX) (Niedernhofer et al., 2004; Rothfuss and Grompe, 2004) . We wanted to test whether KIAA1018 depletion affected the formation and/or persistence of these DSBs. As shown in Figure 7A , 12 hr after MMC treatment, cells pretreated with KIAA1018 or control siRNAs contained 6-fold more g-H2AX foci than untreated controls. These foci reached a maximum at the 24 hr time point and then began to decline. This decline was substantially slower in cells depleted of KIAA1018, such that a considerable number of g-H2AX foci were still present in the cells at the 96 hr time point. However, the KIAA1018-deficient cells do not appear to have a general defect in DSB repair, as treatment with IR induced similar numbers of g-H2AX foci in cells pretreated with siRNA against KIAA1018 and Luc control ( Figure 7B ).
KIAA1018 Deficiency Does Not Affect DSB Resection but Causes Delay in the Disappearance of RPA Foci
Repair of DSBs is accomplished by one of two principal pathways: nonhomologous end-joining (NHEJ) and HR (West, 2003) . DSBs arising through the processing of ICLs are thought to be addressed predominantly by HR, whereby one strand of the broken duplex has to be resected in a 5 0 /3 0 direction to generate long stretches of ssDNA. Given that KIAA1018 has robust exonuclease activity, we wanted to find out whether it might be required for resection. The ssDNA generated during resection is coated first by RPA, and this process can be visualized in the form of RPA foci. As shown in Figure 7C , we observed a substantial increase of RPA foci in MMC-treated cells, but these appeared with similar kinetics in cells pretreated with siRNA against KIAA1018 and Luc. KIAA1018 thus does not appear to be required for DSB resection. However, after 96 hr, the RPA focus number returned nearly to untreated control levels, whereas the siKIAA1018 pretreated cells still displayed numerous foci.
KIAA1018 Is Involved in HR
During HR, RAD51 displaces RPA on the ssDNA to generate filaments that invade homologous sequences on the sister chromatid (West, 2003) . We analyzed the formation and disappearance of RAD51 foci in MMC-treated cells, pretreated with siRNA against KIAA1018 or Luc. We observed a 2-to 3-fold increase in RAD51 foci already in untreated cells, but this difference became less prominent in MMC-treated cells at the 12 and 24 hr time points, when the number of foci reached a maximum. However, at later time points, cells depleted of KIAA1018 contained more than twice as many RAD51 foci as the control ( Figure 7D ). This showed that KIAA1018 is not required for the early HR steps, but rather for their completion. As in the case of g-H2AX foci ( Figure 7B ), no appreciable difference in the number of foci or the kinetics of their appearance and disappearance could be seen in the KIAA1018 and Luc siRNA pretreated cells upon irradiation ( Figure 7E ), which shows that the HR defect is limited to events induced by MMC.
In order to confirm this hypothesis, we deployed the reporter system described by Stark and colleagues (Bennardo et al., 2008) , which monitors successful recombination events between two homologous DNA fragments integrated in the genome of HEK293 cells. Both these fragments encode defective GFP and one carries an engineered recognition site for the I-SceI endonuclease. Transfection of I-SceI cDNA into these cells leads to cleavage of one of the GFP copies. Cells in which the I-SceI-generated DSB is repaired by HR will express GFP. As shown in Figure 7F , HR was almost entirely abolished in cells pretreated with siRNA against RAD51, whereas siRNA against KIAA1018 reduced the efficiency of HR in this system by 30%. This result confirms that KIAA1018 is involved in HR, but its role in the rescue of DSBs that did not arise as intermediates of ICL processing appears to be minor.
KIAA1018 Deficiency Brings about Genomic Instability
Taken together, the evidence presented above implicates KIAA1018 specifically in the processing of damage induced by ICL-generating agents, which is one of the hallmarks of cells from FA patients. The latter cells also display considerable chromosomal instability (Akkari et al., 2000) . Given the phenotypic similarity of FA-and KIAA1018-deficient cells, the dependence of KIAA1018 on FANCD2, and the above DSB repair defect, we examined metaphase chromosome spreads in HEK293 cells depleted either of KIAA1018 or of FANCJ by siRNA. As reported by others (Bridge et al., 2005) , we detected a notable increase in chromosomal instability in FANCJ-depleted cells, where several chromosomal aberrations were frequently seen in single cells (data not shown). In KIAA1018-depleted cells, the chromosomal instability increase was much less pronounced. However, we noted an increase in aberrations already in untreated cells, and MMC treatment induced a 2-fold higher number of aberrations in KIAA1018-depleted cells as compared to the control siRNA pretreated cell population. Importantly, the increase in radial chromosome formation was 5-fold higher than in the control (Figures 7G-7I) . Depletion of KIAA1018 thus brings about chromosomal instability reminiscent of that seen in cells of FA patients.
DISCUSSION
As predicted by bioinformatic analysis (Kinch et al., 2005; Kosinski et al., 2005) , KIAA1018 is indeed a nuclease with both endoand exonuclease activities ( Figure 5, Figure 6 , Figure S3 , and Figure S4 ). Due to its association with FANCD2, we propose to name it FAN1 (FANCD2-associated nuclease 1).
With its preference for 5 0 flaps, FAN1 displays an opposite polarity to the two endonucleases implicated in ICL metabolism to date, MUS81/EME1 and XPF/ERCC1, both of which cleave preferentially 3 0 flaps ( Figure 6G and Ciccia et al., 2008) . MUS81/EME1 is believed to initiate ICL repair by cleaving the leading-strand template of the blocked replication fork ( Figure 1A , step c) and thus generate a one-ended DSB at the fork. The subsequent ''unhooking'' of the lesion ( Figure 1A , step d) was proposed to involve XPF/ERCC1, but this is incongruent with its preference for 3 0 flaps and is thus subject to some controversy (Ciccia et al., 2008) . Recently, Walter and colleagues (Raschle et al., 2008) proposed an alternative mechanism of ICL repair, in which processing of the crosslink initiates only when replication forks traveling in opposite directions converge at the ICL ( Figure 7J ). In this scenario, FAN1 could work in concert with the 3 0 flap-specific enzymes to unhook the ICL by cleaving the lagging-strand template ( Figure 1A and Figure 7J , intermediate a) and thus help generate the substrate for the TLS polymerases Rev1 and pol-z (Raschle et al., 2008) , which could later participate in the HR-mediated repair of the DSBs ( Figure 7J, intermediate b) . FAN1 might be involved also in the resolution of the HR intermediates. Although plausible, this mechanism has two caveats. First, the small size of the plasmid used made it likely that replication forks traveling in opposite directions would reach the ICL almost concurrently. This may not be the case in genomic DNA of higher eukaryotes, where replication origins are far apart. Moreover, ICLs activate a DNA-damage checkpoint that should prevent firing of late (or dormant) origins and thus reduce the chances of two forks colliding. The second caveat concerns the X-structure itself, inasmuch as MUS81/EME1 and/or XPF/ERCC1 could cleave both leading-strand templates of the X to generate two onesided DSBs and a linear, but crosslinked, intermediate ( Figure 7J , structure c). Both termini of this structure could be primerextended to generate a substrate for excision repair. In this scenario, FAN1 would not be involved in the incision of the blocked fork, although it might participate in the repair of the two one-ended DSBs by HR ( Figure 7J, intermediate d) .
Data presented in Figure 7 support the involvement of FAN1 downstream from the replication fork cleavage. FAN1 deficiency affected neither the formation of MMC-induced DSBs, as measured by the appearance of g-H2AX foci ( Figure 7A ), nor their resection, as evidenced by RPA and RAD51 foci formation ( Figures 7C and 7D respectively) . However, it did affect DSB repair. Thus, even though the reduction in HR efficiency as measured by the GFP assay in HEK293 cells ( Figure 7F ) was only slight, the disappearance of RAD51 foci in vivo was substantially delayed ( Figure 7D) . Moreover, the chromosomal breaks and radials observed in FAN1-depleted MMC-treated cells strengthened the notion that FAN1 participates in HR and that, in its absence, MMC-induced lesions are processed erroneously, possibly by NHEJ, to give rise to the observed aberrations. Based on the above observations and coupled with evidence showing that repair of DSBs induced by IR was unaffected by FAN1 status, and that FAN1 depletion did not alter the sensitivity of cells to IR and camptothecin (Figures 2B and 2D) , as well as methyl methane sulfonate (MMS) and HU (data not shown), we propose that FAN1 is required for the processing of recombination intermediates that arise predominantly during the metabolism of damage induced by ICL-generating agents. The elucidation of the molecular role of FAN1 will have to await the results of studies deploying a defined system, such as that described by the Walter laboratory (Raschle et al., 2008) .
Our findings that the recruitment of FAN1 to MMC-induced foci is dependent on FANCD2 ubiquitylation, and that the two proteins appear to physically interact, represent strong evidence in support of an involvement of this nuclease in the FA-dependent pathway of ICL repair. It remains to be seen whether FAN1 is a FA gene. To date, FA patients fall into 13 complementation groups that are linked to mutations in the FANCA, B, C, D1, D2, E, F, G, I, J, L, M, and N genes. However, several patients are yet to be assigned, and we are in the process of screening the DNA of these individuals for germline mutations in FAN1.
EXPERIMENTAL PROCEDURES
cDNA, vectors, antibodies, cell lines, protein purifications, and standard procedures are described in Extended Experimental Procedures.
Immunofluorescence Staining and Laser-Induced Damage U2OS cells cultured on coverslips were mock-treated or treated with 120 ng/ml MMC and fixed 16 or 20 hr later with 3% formaldehyde/PBS for 15 min at 4 C. Membranes were permeabilized with 0.2% Triton X-100 in PBS for 5 min at 4 C. Samples were blocked with 3% nonfat milk/PBS and incubated with primary antibodies overnight at 4 C and with secondary antibodies for 1 hr at 37 C. DNA was stained with DAPI. Slides were analyzed using an Olympus IX81 or a Zeiss LSM710 confocal microscope (sequential scanning mode). Ten micromoles of BrdU was added to the cells 24 hr prior to laser microirradiation. Laser stripes were induced with a laser beam (l = 355 nm) at 50% power using the 403 objective. Cells were fixed 2 hr later.
siRNA Treatments and Cell Survival Assays HEK293 cells were transfected with siRNAs in 6-well plates at 60% confluency using calcium phosphate. For survival assays, cells were seeded 24 hr after transfection in triplicates in 6-well plates at a density of 400 cells per well. Sixteen hours after seeding, the cells were treated with indicated concentrations of MMC, cisplatin, camptothecin, UV, or IR. Medium was replaced 24 hr (MMC and cisplatin), 1 hr (camptothecin), or directly (UV, IR) after treatment. After 8 days, the cells were fixed and stained with 0.5% crystal violet in 20% ethanol and colonies containing more than 50 cells were counted.
Specific Nuclease Assays Endonuclease Assays
One nanomole of labeled substrate was incubated with 10 nmole (or as indicated) of KIAA1018 WT or its variants in 25 mM HEPES-KOH (pH 7.4), 25 mM KCl, 1 mM MnCl 2 or MgCl 2 as indicated, and 0.05 mg/ml BSA for 30 min at 37 C. The reaction was terminated with 0.1% SDS, 14 mM EDTA, and 0.1 mg/ml Proteinase K and incubation at 55 C for 15 min. Loading buffer was added and the samples were separated on a 20% denaturing polyacrylamide gel for 1 hr at 40 V/cm. The gels were dried and the bands were visualized on a PhosphoImager. Exonuclease Assays These were carried out as above, using the substrates indicated at the bottom of the panels in Figure 6E and Figure S4G .
Endonuclease Assays with FLAG-KIAA1018 Immunoprecipitate from HEK293 Cells Stably transfected HEK293 cells expressing 33FLAG-KIAA1018 were grown on 15 cm dishes with G418 to 80% confluency. The cells were pelleted by centrifugation, washed in PBS, and snap-frozen. The pellets were lysed (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton, protease inhibitors) and incubated on ice for 20 min. The lysate was centrifuged and incubated with mouse anti-FLAG M2-Agarose (Sigma) for 2 hr at 4 C on a rotating wheel (300 rpm). Subsequently, the beads were washed twice for 15 min with 500 ml wash buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, and 1 mg/ml BSA), then twice for 15 min with 500 ml with elution buffer (62.5 mM HEPES-KOH pH 7.4, 62.5 mM KCl, 5% glycerol, and 1 mM DTT). FLAG-KIAA1018 was eluted with FLAG-peptides (150 ng/ml, Sigma) in a total volume of 70 ml for 30 min at 4 C on a shaker (600 rpm).
Homologous Recombination Assay
This was carried out essentially as described (Bennardo et al., 2008) . Details can be found in the Extended Experimental Procedures.
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